Scientists discuss how de novo lipogenesis (DNL) contributes to triglyceride overload, the timing of DNL pathway activation with nutrient availability, the sources of acetyl-CoA for DNL, and the sources of NADPH reducing equivalents for DNL.
[NPJ Metabolic Health and Disease]